|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.80 USD | -1.51% |
|
-0.06% | -18.37% |
Company Valuation: Dolby Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 9,375 | 6,589 | 7,494 | 7,231 | 6,938 | 4,975 | - | - |
| Change | - | -29.72% | 13.74% | -3.51% | -4.05% | -28.3% | - | - |
| Enterprise Value (EV) | 8,103 | 5,772 | 7,494 | 7,231 | 6,938 | 4,975 | 4,975 | 4,975 |
| Change | - | -28.77% | 29.85% | -3.51% | -4.05% | -28.3% | 0% | 0% |
| P/E | 31.1x | 37.3x | 38.2x | 28.2x | 27.6x | 16.2x | 14.9x | 14.4x |
| PBR | 3.6x | 2.88x | - | - | 2.65x | 1.87x | - | - |
| PEG | - | -1x | 2.9x | 0.9x | -10.61x | 0.7x | 1.67x | 5.1x |
| Capitalization / Revenue | 7.32x | 5.26x | 5.77x | 5.68x | 5.14x | 3.54x | 3.4x | 3.22x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 3.54x | 3.4x | 3.22x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 9.24x | 8.72x | 8.05x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 17x | 14.5x | 12.5x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 14.6x | 9.97x | 9.2x |
| FCF Yield | 4.2% | 4.11% | 4.49% | 4.11% | 6.28% | 6.84% | 10% | 10.9% |
| Dividend per Share 2 | 0.91 | 1.02 | 1.11 | - | 1.32 | - | - | - |
| Rate of return | 0.98% | 1.51% | 1.42% | - | 1.82% | - | - | - |
| EPS 2 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 | 3.25 | 3.54 | 3.64 |
| Distribution rate | 30.6% | 56.4% | 54.1% | - | 50.4% | - | - | - |
| Net sales 1 | 1,281 | 1,254 | 1,300 | 1,274 | 1,349 | 1,406 | 1,464 | 1,546 |
| EBITDA 1 | 550.2 | 420.6 | 463.9 | 460.1 | 496.3 | 538.6 | 570.4 | 618.1 |
| EBIT 1 | 344.4 | 206.6 | 215.8 | 258.3 | 265 | 293.4 | 342.2 | 398.6 |
| Net income 1 | 310.2 | 184.1 | 200.7 | 261.8 | 255 | 258.7 | 296.4 | 347.5 |
| Net Debt | -1,272 | -817.6 | - | - | - | - | - | - |
| Reference price 2 | 92.47 | 67.46 | 78.36 | 75.84 | 72.39 | 52.59 | 52.59 | 52.59 |
| Nbr of stocks (in thousands) | 101,387 | 97,677 | 95,641 | 95,348 | 95,844 | 94,598 | - | - |
| Announcement Date | 16/11/21 | 17/11/22 | 16/11/23 | 19/11/24 | 18/11/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 16.18x | - | - | - | 4.97B | ||
| -342.09x | 6.44x | 24.04x | -.--% | 23.68B | ||
| 168.84x | 0.93x | 11.82x | -.--% | 7.73B | ||
| 56.33x | 1.4x | 10.06x | -.--% | 3.35B | ||
| 21.65x | - | - | - | 433M | ||
| -12.26x | - | - | - | 417M | ||
| Average | -15.22x | 2.92x | 15.31x | 0% | 6.76B | |
| Weighted average by Cap. | -160.74x | 4.73x | 19.98x | 0% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DLB Stock
- Valuation Dolby Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















